You are here:

Research

10 June 2016

Amy Bowen from the MS Trust explains how it gets to the nub of the issues surrounding stem cell therapy for MS and why it's time for a roadmap for making the treatment safe and widely available on the NHS.

Read more

07 June 2016
Consortium of Multiple Sclerosis Centers MS in the media

Reports of studies presented at the CMSC (Consortium of Multiple Sclerosis Centers) meeting that took place from 1-4 June 2016.  Reports include research into  drugs for MS, better understanding of symptoms and lifestyle factors.

Read more

03 June 2016
Overall health matters Amy Bowen

Amy Bowen, the MS Trust's Director of Service Development, reports from the CMSC conference on two talks about the importance of lifestyle issues and MS

Read more

22 April 2016
American Academy of Neurology (AAN)

Reports of studies presented at the American Academy of Neurology meeting that took place from 15-21 April 2016.  Reports include researchinto disease modifying drugs for relapsing MS, approaches to repair of nerves and risk factors for MS.

Read more

20 January 2016
magnifying glass

In short, yes it could. The recent Panorama programme focussed on people with relapsing MS, but many people are asking whether people with progressive MS could be helped too.

In this blog, Jane from the Information Team looks at some of the research so far, what’s possible now and where we might expect to see further progress in the future.

Read more

02 December 2015
Is stem cell therapy right for my MS

There is an increasing interest in stem cell therapy for multiple sclerosis. Perhaps you are debating whether it could be a treatment option for you either now or in the future?

In this blog, Jane from the Information Team at the MS Trust, looks at some of the issues surrounding this largely experimental treatment.

Read more

07 October 2015
A new focus on brain health: Amy Bowen reports from ECTRIMS 2015

Amy Bowen, our Director of Service Development, reports from ECTRIMS 2015 on what is widely expected to be the most significant MS conference for many years

Read more

11 May 2015

The issue of vaccinations and multiple sclerosis raises a number of questions for people with MS. Are the treatments safe? Do they work in MS? Are they affected by other treatments? Here we look at some of the more frequently asked questions.

Read more

11 May 2015

There have recently been encouraging developments in understanding and treating progressive MS. In this issue of Open Door we report on MS Trust research into the experience of transition between relapsing and secondary progressive MS and hear from Dr Jeremy Chataway on his research into the effects of three drugs on people with secondary progressive MS. To introduce the feature, Professor Alan Thompson, who is co-chair of team that coordinates the International Progressive MS Alliance’s research programme, explains how the focus has changed.

Read more

11 November 2014
Head graphic full of thoughts

About half of all people with MS have problems at some time with aspects of memory, attention span or concentration. Dawn Langdon, Professor of Neuropsychology at Royal Holloway, University of London, looks at promising research into MS and memory.

Read more

16 May 2014

As this edition of Open Door hits your doormat the preliminary results of the Department of Health Risk-sharing Scheme (RSS) will have been presented at the Association of British Neurologists meeting, and by the next edition we hope the full results will have been published in the Lancet or BMJ.

Read more

04 February 2013

Many people are intensely interested in what is happening in MS research. On Saturday, I was lucky enough to go to a Research Day held by Barts and The London School of Medicine and Dentistry, with UCL Partners, to hear what research they are doing and what it might mean for people with MS. This research group includes some of the top researchers in MS in the UK and they are keen to get people involved. The audience were mostly people with MS, their friends and family.

Read more

06 May 2010

Dr George Gveric writes about the work of the UK Multiple Sclerosis Tissue Bank, which was set up to fulfil wishes of those who wanted to help MS research by donating brain and spinal cord tissue, and to provide a resource for scientists investigating various aspects of MS

Read more